IBRX270115C00022000
IBRX Jan 15 2027 22.00 Call
optionOPRA
EODOct 19, 2026
0.15USD-40.000%(-0.10)55Vol7,860OI
Loading…
Underlying
Underlying Price
$8.69
Type
Call
Strike
22
Expiration
Jan 15, 2027
DTE
87d
Moneyness
OTM
Intrinsic
$0.00
IBRX 22 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Jan 15, 2027 | 87d | $0.15 | -40.00% | 55 | 7,860 |
| Jan 21, 2028 | 458d | $1.15 | -11.54% | 127 | 7,925 |
IBRX Profile
immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.